{
    "nctId": "NCT04496492",
    "briefTitle": "Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial.",
    "officialTitle": "Preoperative Use of Tocotrienol Associated With Personalized Nutritional and Psychoeducational Support in Women With Primary Breast Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Changes in blood oxidant capacity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* histologically confirmed operable primary breast cancer (T1-T2 N0-1 M0)\n* absence of distant metastasis\n* signed informed consent.\n\nExclusion Criteria:\n\n* Previous malignancies other than in situ cervical carcinoma or nonmelanoma skin cancer\n* Breast cancer recurrence\n* Metastatic breast cancer\n* Non-epithelial breast cancer at histological examination\n* In situ lobular breast cancer\n* Participation in other randomized clinical trials that could interfere with current study\n* Living distant from center and unable to attend for check-ups and meetings",
    "sex": "ALL",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}